In a memo released Friday and effectively immediately, CMS officials wrote that reimbursement for TENS for low back pain will be available only when patients are participating in a randomized, controlled trial to gauge the clinical effectiveness of the treatment.
“TENS is not reasonable and necessary for the treatment of [chronic low back pain],” the memo said. “Long-standing use of a medical treatment is unfortunately no guarantee that it is in fact clinically appropriate or necessary.”
Medicare previously paid for FDA-approved TENS equipment and supplies when prescribed by a physician for chronic pain and reimbursed physicians and physical therapists for evaluating patients’ suitability for the treatment.
More Articles on Pain Management:
Post-Operative Pain Drug Yields Positive Trial Results
Mallinckrodt and Zogenix to Collaborate on Migraine Treatment
50 Pain Management Physician Medical Directors
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
